PubMed

The nephrotoxic effects of HAART.

Izzedine H, Harris M, Perazella MA.

Nat Rev Nephrol. 2009 Oct;5(10):563-73.PMID: 19776778 [PubMed - in process]Related articles

A randomized, open-label study of a nucleoside analogue reverse transcriptase inhibitor-sparing regimen in antiretroviral-naive HIV-infected patients.

Harris M, Côté H, Ochoa C, Allavena C, Negredo E, Thorne A, Cahn P, Zala C, Raffi F, Clotet B, Singer J, Montaner J; CTN 177 Study Team.

J Acquir Immune Defic Syndr. 2009 Mar 1;50(3):335-7. No abstract available. PMID: 19242263 [PubMed - indexed for MEDLINE]Related articles

Lopinavir/ritonavir pharmacokinetics in a substitution of high-dose soft-gelatin capsule to tablet formulation.

Hull MW, Harris M, Lima V, Guillemi S, Harrigan PR, Montaner JS.

J Clin Pharmacol. 2009 Feb;49(2):155-61.PMID: 19179294 [PubMed - indexed for MEDLINE]Related articles

A comparison of the predictive performance of different methods of kidney function estimation in a well-characterized HIV-infected population.

Barraclough K, Er L, Ng F, Harris M, Montaner J, Levin A.

Nephron Clin Pract. 2009;111(1):c39-48. Epub 2008 Dec 3.PMID: 19052469 [PubMed - indexed for MEDLINE]Related articles

Exacerbation of depression associated with starting raltegravir: a report of four cases.

Harris M, Larsen G, Montaner JS.

AIDS. 2008 Sep 12;22(14):1890-2. No abstract available. PMID: 18753871 [PubMed - indexed for MEDLINE]Related articles

Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients.

Harris M.

Expert Opin Drug Saf. 2008 Jul;7(4):389-400. Review.PMID: 18613803 [PubMed - indexed for MEDLINE]Related articles

Outcomes of multidrug-resistant patients switched from enfuvirtide to raltegravir within a virologically suppressive regimen.

Harris M, Larsen G, Montaner JS.

AIDS. 2008 Jun 19;22(10):1224-6.PMID: 18525270 [PubMed - indexed for MEDLINE]Related articles

Canadian Consensus Recommendations for the Optimal Use of Enfuvirtide in HIV/AIDS Patients.

Rachlis A, Angel J, Harris M, Lalonde R, Smaill F, Tremblay C, Tsoukas C, Walmsley S.

Can J Infect Dis Med Microbiol. 2006 May;17(3):155-63.PMID: 18418493 [PubMed - in process]Related articlesFree article

Stopping antiretroviral therapy: easier said than done.

Hull M, Harris M, Montaner JS.

AIDS. 2007 Aug 20;21(13):1817-8. No abstract available. PMID: 17690582 [PubMed - indexed for MEDLINE]Related articles

An unusual case of acute kidney injury due to vancomycin lessons learnt from reliance on eGFR.

Barraclough K, Harris M, Montessori V, Levin A.

Nephrol Dial Transplant. 2007 Aug;22(8):2391-4. Epub 2007 Apr 30.PMID: 17470454 [PubMed - indexed for MEDLINE]Related articlesFree article

Special Access Denied: A Case Study of Health Canada's Special Access Program.

Christie TK, Harris M, Montaner JS.

Healthc Policy. 2006 Nov;2(2):27-34.PMID: 19305701 [PubMed - in process]Related articlesFree article

Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy.

Côté HC, Magil AB, Harris M, Scarth BJ, Gadawski I, Wang N, Yu E, Yip B, Zalunardo N, Werb R, Hogg R, Harrigan PR, Montaner JS.

Antivir Ther. 2006;11(1):79-86.PMID: 16518963 [PubMed - indexed for MEDLINE]Related articles

Transient neuropathy after needle-free injection outside of recommended sites.

Harris M, Larsen G, Valyi M, Walker E, Montaner JS.

AIDS. 2006 Mar 21;20(5):784-5. No abstract available. PMID: 16514315 [PubMed - indexed for MEDLINE]Related articles

Enfuvirtide plasma levels and injection site reactions using a needle-free gas-powered injection system (Biojector).

Harris M, Joy R, Larsen G, Valyi M, Walker E, Frick LW, Palmatier RM, Wring SA, Montaner JS.

AIDS. 2006 Mar 21;20(5):719-23.PMID: 16514302 [PubMed - indexed for MEDLINE]Related articles

Treatment interruption of highly active antiretroviral therapy in patients with nadir CD4 cell counts >200 cells/mm3.

Toulson AR, Harrigan R, Heath K, Yip B, Brumme ZL, Harris M, Hogg RS, Montaner JS.

J Infect Dis. 2005 Nov 15;192(10):1787-93. Epub 2005 Oct 5.PMID: 16235178 [PubMed - indexed for MEDLINE]Related articles

Management of HIV-infected patients with multidrug-resistant virus.

Harris M, Montaner JS.

Curr HIV/AIDS Rep. 2004 Sep;1(3):116-21. Review.PMID: 16091231 [PubMed - indexed for MEDLINE]Related articles

Structured treatment interruptions: a risky business.

Montaner J, Harris M, Hogg R.

Clin Infect Dis. 2005 Feb 15;40(4):601-3. Epub 2005 Jan 26. No abstract available. PMID: 15712084 [PubMed - indexed for MEDLINE]Related articles

Simplification of therapeutic drug monitoring for twice-daily regimens of lopinavir/ritonavir for HIV infection.

Alexander CS, Montaner JS, Asselin JJ, Ting L, McNabb K, Harris M, Guillemi S, Harrigan PR.

Ther Drug Monit. 2004 Oct;26(5):516-23.PMID: 15385834 [PubMed - indexed for MEDLINE]Related articles

Combination therapy with fenofibrate and rosiglitazone paradoxically lowers serum HDL cholesterol.

Normén L, Frohlich J, Montaner J, Harris M, Elliott T, Bondy G.

Diabetes Care. 2004 Sep;27(9):2241-2. No abstract available. PMID: 15333491 [PubMed - indexed for MEDLINE]Related articlesFree article

Life-threatening reaction after first ever dose of abacavir in an HIV-1-infected patient.

de la Rosa R, Harris M, Uyeda L, Goodison K, Keown P, Montaner JS.

AIDS. 2004 Feb 20;18(3):578-9. No abstract available. PMID: 15090818 [PubMed - indexed for MEDLINE]Related articles